- ►hematologylibrary.org A Tefferi, J Thiele, A Orazi, HM Kvasnicka, T … - Blood, 2007 - bloodjournal.hematologylibrary.org The Janus kinase 2 mutation, JAK2617V>F, is myeloid neoplasm-specific; its
presence excludes secondary polycythemia, thrombocytosis, or bone marrow
fibrosis from other causes. Furthermore, JAK2617V>F or a JAK2 exon 12 ... Cited by 236 - Related articles - BL Direct - All 5 versions
- ►cell.com C James, V Ugo, N Casadevall, SN … - Trends in molecular medicine, 2005 - Elsevier Myeloproliferative disorders include several pathologies sharing the common
feature of being clonal hematopoietic stem cell diseases. The molecular basis of
chronic myeloid leukemia was characterized many years ago with the ... Cited by 59 - Related articles - All 7 versions
G Finazzi, C Harrison - Seminars in hematology, 2005 - Springer Essential thrombocythemia (ET) is currently classified as a myeloproliferative
disorder (MPD), which is a heterogeneous category of clonal stem cell diseases
that also includes polycythemia vera (PV), myelofibrosis with myeloid ... Cited by 39 - Related articles - BL Direct - All 12 versions
- ►hematologylibrary.org JL Spivak, RT Silver - Blood, 2008 - bloodjournal.hematologylibrary.org In its August 15, 2007, issue, Blood published a proposal for revision of the
World Health Organization (WHO) diagnostic criteria for the chronic
myeloproliferative disorders (MPDs) polycythemia vera (PV), essential ... Cited by 29 - Related articles - All 3 versions
J Thiele, HM Kvasnicka - Leukemia & lymphoma, 2006 - informahealthcare.com Following the introduction of the WHO classification of chronic
myeloproliferative disorders (MPDs), after approximately 5 years, a critical
reappraisal appears to be warranted. Retrospective clinico-pathological ... Cited by 27 - Related articles - BL Direct - All 7 versions
A Tefferi, JW Vardiman - Current opinion in hematology, 2007 - journals.lww.com Purpose of review The sighting of the Philadelphia chromosome in 1960, later
shown to harbor the BCR-ABL mutation in chronic myeloid leukemia, is arguably
the most seminal contribution to molecular oncology. In the decades that ... Cited by 24 - Related articles - BL Direct - All 3 versions
J Thiele, HM Kvasnicka, J Vardiman - Best Practice & Research Clinical Haematology, 2006 - Elsevier Histopathology of bone marrow (BM) biopsies plays a crucial role in the
interdisciplinary approach to diagnosis and classification of chronic
myeloproliferative disorders (CMPDs). Based on careful clinicopathologic ... Cited by 22 - Related articles - All 3 versions
J Thiele, HM Kvasnicka, V Diehl - Acta Haematol, 2005 - content.karger.com Patients have previously been described who showed clinical signs and symptoms
suggesting essential thrombocythemia (ET), but later transformed to polycythemia
vera (PV). From a series of 344 patients with a sustained borderline to ... Cited by 17 - Related articles - All 6 versions
- ►hematologylibrary.org AM Vannucchi, T Barbui - Hematology, 2007 - asheducationbook.hematologylibrary.org The aim of this review is to discuss current diagnostic approaches to, and
classification of, patients presenting with thrombocytosis, in light of novel
information derived from the discovery of specific molecular abnormalities ... Cited by 14 - Related articles - All 3 versions
G Finazzi, XT Gregg, T Barbui, JT Prchal - Best Practice & Research Clinical Haematology, 2006 - Elsevier Idiopathic erythrocytosis (IE) is characterized by an increase of red blood cell
mass without an identified cause. Its diagnosis is based on the exclusion of
polycythemia vera (PV), secondary acquired polycythemias and various ... Cited by 14 - Related articles - All 3 versions
